Preclinical Validation of New Anti-melanoma Compounds

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Melanoma
Trial Locations (1)

06000

Nice hospital, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT03798977 - Preclinical Validation of New Anti-melanoma Compounds | Biotech Hunter | Biotech Hunter